Seoulin Bioscience Co.Ltd Cash Flow Quality Index
Seoulin Bioscience Co.Ltd cash flow quality index. Seoulin Bioscience Co.Ltd (038070) has a Cash Flow Quality Index of 3.62x as of September 2025. Operating cash flow of ₩2.78 Billion exceeds net income of ₩766.93 Million, indicating high earnings quality where cash backs reported profits. See Seoulin Bioscience Co.Ltd (038070) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Seoulin Bioscience Co.Ltd (2013–2025)
Cash flow quality index of Seoulin Bioscience Co.Ltd from 2013 to 2025. Historical Cash Flow Quality Index for Seoulin Bioscience Co.Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 038070 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Seoulin Bioscience Co.Ltd Cash Flow Quality Index by Year (2013–2025)
Seoulin Bioscience Co.Ltd cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for Seoulin Bioscience Co.Ltd. For the full cash flow conversion analysis, see 038070 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 6.50x | ₩4.76 Billion | ₩731.98 Million | ▲ +542.8% |
| 2024 | -1.47x | ₩-4.61 Billion | ₩3.14 Billion | ▼ -221.7% |
| 2022 | -0.46x | ₩-4.36 Billion | ₩9.54 Billion | ▼ -179.8% |
| 2021 | 0.57x | ₩8.92 Billion | ₩15.59 Billion | ▼ -24.0% |
| 2020 | 0.75x | ₩3.68 Billion | ₩4.89 Billion | ▼ -8.6% |
| 2019 | 0.82x | ₩7.32 Billion | ₩8.88 Billion | ▼ -48.2% |
| 2018 | 1.59x | ₩4.17 Billion | ₩2.62 Billion | ▲ +151.9% |
| 2017 | 0.63x | ₩1.30 Billion | ₩2.06 Billion | ▼ -4.7% |
| 2016 | 0.66x | ₩2.76 Billion | ₩4.16 Billion | ▼ -70.6% |
| 2015 | 2.26x | ₩4.12 Billion | ₩1.83 Billion | ▲ +119.7% |
| 2014 | 1.03x | ₩2.74 Billion | ₩2.67 Billion | ▼ -13.5% |
| 2013 | 1.19x | ₩4.94 Billion | ₩4.16 Billion | — |